Health professionals
Overview Register Login
Regenerative therapy History of regenerese

 

History of REGENERESEN

(Note: REGENERESEN are no longer permitted and therefore not marketable.)

 

Proven therapy concepts are the basis for therapists who carry out a holistic treatment with natural remedies. Here we give a review of a therapy principle more than 50 years old.


For more than 50 years, REGENERESEN® has been used in Germany as a drug to support the treatment of patients with chronic and degenerative diseases as part of complementary therapies. The active ingredient, extracted from bovine organs and yeast, was the purified sodium salt of ribonucleic acids (RNA-Na). Millions of treatments have been performed during this period. Since 2012, REGENRESEN have no longer been commercially available in Germany due to a lack of approval as a finished drug. The treatment concept was based on an individual combination of approx. 50 extracts from different organs, which followed the principle of a holistic, organ-specific therapy, including all affected organ systems.

 

This therapy was based on the following special REGENERESEN®:

 

RN13® REGENERESEN®

with ribonucleic acids from:


Vascular wall, cerebral cortex, heart, pituitary gland, hypothalamus, liver, spleen, adrenal cortex, kidney, ovary, placenta, testes, thalamus (bovine) and yeast.

The basic therapeutic RN 13 was used for the supportive treatment of geriatric complaints, age-related endocrine involution, general wear and tear, to increase resistance (increase the immune defence) and to maintain strength potential.

 

OSTEOCHONDRIN®S

with ribonucleic acids from:

intervertebral disc, cartilage, synovia, placenta (bovine) and yeast

Osteochondrin® S was used for the supportive treatment of osteochondrosis, osteoporosis, arthrosis, spondylosis and brachialgia.

 

AU 4® REGENERESEN®

with ribonucleic acids from:


auditory pathway, auditory nerve, auditory centre, inner ear (bovine) and yeast

 

AU 4 was used for supportive treatment of old-age hearing loss, degenerative diseases of the inner ear, acute hearing loss, drug and toxic damage to the inner ear.

 

 

In addition to these special preparations, a selection could be made from approx. 50 other organ varieties:

 

REGENERESEN®

with ribonucleic acids from:

individual organs from cattle and yeast

Used for supportive treatment of chronic and degenerative diseases in which protein synthesis and - as far as related - incremental functions were impaired.